share_log

Reneo Pharmaceuticals Q3 EPS $(0.53) Down From $(0.52) YoY

Reneo Pharmaceuticals Q3 EPS $(0.53) Down From $(0.52) YoY

Reneo PharmPharmticals第三季度每股收益为0.53美元,较上年同期下降0.52美元
Benzinga Real-time News ·  2022/11/08 07:43

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.53) per share. This is a 1.92 percent decrease over losses of $(0.52) per share from the same period last year.

雷诺制药公司(纳斯达克代码:RPHM)公布季度每股亏损0.53美元。这比去年同期每股亏损0.52美元减少了1.92%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发